Michael Magliochetti, Ph.D, has joined Boston's Riverside Partners as an operating partner. Dr. Magliochetti has over twenty years of healthcare operating and acquisition experience, most recently as CEO of Claros Diagnostics, a point-of-care in-vitro diagnostic firm. He was also previously an entrepreneur-in-residence at Oxford Bioscience Partners. Riverside Partners is a middle-market private equity firm focused on the healthcare and technology industries.
